交易中 03-27 10:03:21 美东时间
0.000
0.00%
Radiopharm Theranostics has dosed the first patient in a Phase 1 trial of 177Lu-RAD202, targeting HER2-positive advanced solid tumors. The 'HEAT' trial aims to assess safety, tolerability, and efficacy of this novel radiotherapeutic, with earlier data supporting its potential. The study is conducted across Australia, targeting patients with aggressive cancers like breast, ovarian, and gastric. This milestone underscores the company's commitment to addressing unmet needs in oncology.
2025-06-04 12:00
瑞银周一发表研报称,英伟达与甲骨文将成为得州“星际之门”AI数据中心的主要受益方。据该机构预估,该项目或为英伟达带来高达200亿美元的GPU收入,同时为甲骨文云基础设施(OCI)创造超20亿美元收益。 这座位于得州阿比林的数据中心全面建成后,预计将部署40万块英伟达GB200 GPU——按当前定价相当于约200亿美元销售额,随着OpenAI通过甲骨文、微软和CoreWeave扩大算力规模,还将额外带来50亿美元网络设备收入。 而甲骨文OCI仅第一阶段就将托管10万块GPU集群,推动至少20亿美元营收,随着OpenAI将更多工作负载从微软迁移,可能引发“重大订单积压事件”。 对O...
2025-06-02 22:55
Radiopharm Theranostics announced favorable preclinical data for RV01, a B7-H3-targeted radiopharmaceutical, showing high tumor uptake and favorable biodistribution. The modified monoclonal antibody has a shorter half-life, reducing off-target exposure and potential toxicities. IND submission is expected mid-2025, with a first-in-human Phase 1 study planned for Q4 2025.
2025-06-02 12:00
【亿邦原创】日前,鞋服品牌跨境大卖子不语公布了2024年业绩:收入约33.25亿元,同比增长10.83%;毛利约24.71亿元,同比增长26.39%;归母净利润...
2025-03-28 18:48
百心安-B(02185)公布,于2025年2月,该公司附属公司上海安通医疗科技有限公司(安通)研发的Iberis®多极肾动脉射频消融系统(Iberis®RDN系...
2025-03-03 20:11
IT之家 1 月 14 日消息,网传杭州临平一家上市公司官宣实施 4.5 天工作制,周五只上半天班,且公司不降薪、不裁员。对此消息,这家公司的工作人员昨日向橙柿...
2025-01-14 10:54